UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018552
Receipt number R000020922
Scientific Title Screening of cardiovascular, cerebrovascular, and renal disease for residents in rural areas using a medical IT network
Date of disclosure of the study information 2015/08/05
Last modified on 2023/08/14 12:18:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Screening of cardiovascular, cerebrovascular, and renal disease for residents in rural areas using a medical IT network

Acronym

Screening of disease for residents in rural areas using a medical IT network

Scientific Title

Screening of cardiovascular, cerebrovascular, and renal disease for residents in rural areas using a medical IT network

Scientific Title:Acronym

Screening of disease for residents in rural areas using a medical IT network

Region

Japan


Condition

Condition

cardiovascular disease, cerebrovascular disease, renal disease

Classification by specialty

Cardiology Nephrology Neurology
Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To formulate the guideline to improve prognosis of residents in rural areas by intervention by specialists via medical information network

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The difference of incidence of cardiovascular, cerebrovascular, or renal diseases between residents in rural areas with intervention by specialists via the medical information network and those without the intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment Other

Interventions/Control_1

Intervention group gets advices from specialists in Sendai area via medical information network.

Interventions/Control_2

Non-intervention group is followed up by doctors in each area.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Men and women living in other than Sendai area aged 65 years or over with low or middle risk for cardiovascular diseases determined by existing guidelines

Key exclusion criteria

-Patients with history of stroke, myocardial infarction, or severe cardiovascular diseases within six month
-BNP is 200pg/mL or over
-eGFR is less than 30mL/min/1.73m2 or albumin creatinine ratio in urin is 300mg/gCr or over
-Patient ineligible to this study due to other medical reasons

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Masaharu
Middle name
Last name Nakayama

Organization

Tohoku University

Division name

Department of Medical Informatics, Tohoku University School of Medicine

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Japan

TEL

022-717-7572

Email

nakayama@cardio.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Masaharu
Middle name
Last name Nakayama

Organization

Tohoku University

Division name

Department of Medical Informatics, Tohoku University School of Medicine

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Japan

TEL

022-717-7572

Homepage URL


Email

nakayama@cardio.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Akita University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Tohoku University School of Medicine

Address

2-1, Seiryo-machi, Aoba-ku, Sendai, Japan

Tel

022-728-4105

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 05 Day


Related information

URL releasing protocol

https://rctportal.niph.go.jp/s/detail/um?trial_id=UMIN000018552

Publication of results

Published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/34107543/

Number of participants that the trial has enrolled

1092

Results

1029 subjects living in the rural areas were randomly assigned to an intervention group in which general practitioners (GPs) were advised by specialists through health information exchange or a control group in which GPs received no advice. All-cause mortality and cumulative incidence of serious adverse events did not differ between the groups. However, per-protocol analysis controlling for GP adherence with specialist recommendations revealed significantly reduced them in the intervention group.

Results date posted

2023 Year 08 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

We evaluated the clinical data of 1,092 patients aged >=65 years living in the rural areas of the Miyagi Prefecture and receiving care from general practitioners (GPs) only. Low-to-moderate risk patients were randomly assigned to an intervention group in which GPs were advised by specialists through health information exchange (n = 518, 38% male, mean age = 76 +/- 7 years) or a control group in which GPs received no advice by specialists (n = 521, 39% male, mean age = 75 +/- 7 years).

Participant flow

A total of 1,090 patients were enrolled from November 2015 to September 2016 (39% men, mean age = 76 +/- 7 years, range = 65-94 years). Fifty-one high-risk patients were immediately referred to specialists. Simple randomization was used to assign low-to-moderate risk patients to either the intervention group or control group. The assignment was disclosed to the enrolled patients. The 1,039 patients with low-to-moderate risk were then randomly assigned to an intervention group (n = 518, 38% men, mean age = 76 +/- 7 years) or a usual care (control) group (n = 521, 39% men, mean age = 75 +/- 7 years). In the intervention group, specialists evaluated each participant's risk and provided recommendations to the general practitioner, who then decided whether to alter the treatment strategy. However, 6 months after the first recommendation, specialists provided additional comments to the general practitioners. We conducted follow-up assessments at 6 months and 1 year to evaluate general practitioner's adherence to recommendations and current risks among patients.

Adverse events

None.

Outcome measures

The difference of incidence of cardiovascular, cerebrovascular, or renal diseases between residents in rural areas with intervention by specialists via the medical information network and those without the intervention.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2015 Year 06 Month 25 Day

Date of IRB

2015 Year 10 Month 01 Day

Anticipated trial start date

2015 Year 10 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients meeting exclusion criteria are not included in the intervention trial, and they are included in the observational study. The patients at high risk are encouraged to visit specialists at the beginning of observation. The subjects are followed up after six month, and if they do not visit specialists, they are encouraged to visit specialists again. They are followed up after one year, and data on outcome are collected.


Management information

Registered date

2015 Year 08 Month 05 Day

Last modified on

2023 Year 08 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020922


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name